Zeitschriftenaufsatz
|
2017
The good and the bad faces of STAT1 in solid tumours
Autor:in
Meissl, Katrin; Macho-Maschler, Sabine; Mueller, Mathias; Strobl, Birgit
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Abstrakt
Signal transducer and activator of transcription (STAT) 1 is part of the Janus kinase (JAK)/STAT signalling cascade and is best known for its essential role in mediating responses to all types of interferons (IFN). STAT1 regulates a variety of cellular processes, such as antimicrobial activities, cell proliferation and cell death. It exerts important immune modulatory activities both in the innate and the adaptive arm of the immune system. Based on studies in mice and data from human patients, STAT1 is generally considered a tumour suppressor but there is growing evidence that it can also act as a tumour promoter. This review aims at contrasting the two faces of STATI in tumourigenesis and providing an overview on the current knowledge of the underlying mechanisms or pathways. (C) 2015 The Authors. Published by Elsevier Ltd.
Schlagwörter
Tumour suppressor; Immune surveillance; Cytokine signalling; Cell proliferation and death; Acquired therapy resistance
Dokumententyp
Übersichtsarbeit
CC Lizenz
CCBYNCND
Open Access Type
Hybrid
ISSN/eISSN
1043-4666 - 1096-0023
WoS ID
PubMed ID